{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:31:33Z","timestamp":1787239893196,"version":"build-2736575974"},"reference-count":0,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IDR"],"DOI":"10.2147\/idr.s171338","type":"journal-article","created":{"date-parts":[[2019,7,22]],"date-time":"2019-07-22T22:09:17Z","timestamp":1563833357000},"page":"2259-2268","source":"Crossref","is-referenced-by-count":18,"title":["<p>Profile of sofosbuvir\/velpatasvir\/voxilaprevir in the treatment of hepatitis C<\/p>"],"prefix":"10.2147","volume":"Volume 12","author":[{"given":"Lindsey M.","family":"Childs-Kean","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0413-5896","authenticated-orcid":true,"given":"Natalie A.","family":"Brumwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma F.","family":"Lodl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2019,7]]},"container-title":["Infection and Drug Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=51442","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=51442","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,22]],"date-time":"2019-07-22T22:09:17Z","timestamp":1563833357000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/profile-of-sofosbuvirvelpatasvirvoxilaprevir-in-the-treatment-of-hepat-peer-reviewed-article-IDR"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":0,"URL":"https:\/\/doi.org\/10.2147\/idr.s171338","relation":{},"ISSN":["1178-6973"],"issn-type":[{"value":"1178-6973","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7]]}}}